TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells-Reference-Cited by-同舟云学术

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

Published:2015-06-19 Issue:6 Volume:10 Page:e0129838
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Otani Hiroki,Yamamoto Hiromasa,Takaoka Munenori,Sakaguchi Masakiyo,Soh Junichi,Jida Masaru,Ueno Tsuyoshi,Kubo Takafumi,Asano Hiroaki,Tsukuda Kazunori,Kiura Katsuyuki,Hatakeyama Shinji,Kawahara Eiji,Naomoto Yoshio,Miyoshi Shinichiro,Toyooka Shinichi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Cancer statistics, 2014;R Siegel;CA Cancer J Clin,2014

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;JH Schiller;N Engl J Med,2002

3. Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers;T Fukui;Gen Thorac Cardiovasc Surg,2008

4. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung;H Suehisa;J Clin Oncol,2007

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer;T Fong;J Thorac Oncol,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal adhesion kinase inhibitors, a heavy punch to cancer;Discover Oncology;2021-11-22

2. The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia;Frontiers in Cell and Developmental Biology;2021-03-09

3. TAE226, a dual inhibitor of focal adhesion kinase and insulin‐like growth factor‐I receptor, is effective for Ewing sarcoma;Cancer Medicine;2019-11-06

4. Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models;BMC Research Notes;2019-06-18

5. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer;Molecular Cancer Therapeutics;2018-10-23